✦ LIBER ✦

Interferon production by lymphocytes from patients with systemic lupus erythematosus

✍ Scribed by Dr Donato Alarcon-Segovia; Juan Ruiz-Gomez; Eugenia Fishbei; Marfa Elena Bustamante

Publisher: John Wiley and Sons
Year: 1974
Tongue: English
Weight: 200 KB
Volume: 17
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780170513

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon production in patients with s

Interferon production in patients with systemic lupus erythematosus

✍ Robert M. Friedman; Olivia Preble; Roberta Black; Sharon Harrell 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 2 views

Lymphocyte subsets in patients with syst

Lymphocyte subsets in patients with systemic lupus erythematosus

✍ Raphael J. Dehoratius 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 470 KB 👁 2 views

Direct lysis of lymphocytes by complemen

Direct lysis of lymphocytes by complement in patients with systemic lupus erythematosus

✍ Dr. Peter Stastny; Morris Ziff 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 1 views

The response of cultured lymphocytes fro

The response of cultured lymphocytes from patients with systemic lupus erythematosus to DNA

✍ Aiua Patrucco; Naomi F. Rothfield; Kurt Hirschhorn 📂 Article 📅 1967 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 1 views

Periodicity of interferon appearance in

Periodicity of interferon appearance in serum of patients with systemic lupus erythematosus

✍ Vladimir Lackovič; Ladislav Borecky; Jozef Rovensky; Dušan Žitnan; Jozef Lukác; 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 2 views

B lymphocyte stimulator overexpression i

B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: Longitudinal observations

✍ William Stohl; Samy Metyas; Soon-Min Tan; Gurtej S. Cheema; Bonifacia Oamar; Don 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 1 views

## Abstract ## Objective To assess the overexpression of B lymphocyte stimulator (BLyS) over time in patients with systemic lupus erythematosus (SLE). ## Methods Sixty‐eight SLE patients were followed up longitudinally for a median 369 days. At each physician encounter, disease activity was asse